Details of the Drug

General Information of Drug (ID: DM5EZWZ)

Drug Name
RG6501
Indication
Disease Entry ICD 11 Status REF
Geographic atrophy 9B75 Phase 1 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D4D6XG

References

1 Clinical pipeline report, company report or official report of Roche